Intellia Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.4M | 488k | 17.27 |
| 2025-06-30 | $4.9M | 518k | 9.38 |
| 2025-03-31 | $1.7M | 240k | 7.16 |
| 2024-12-31 | $3.6M | 312k | 11.66 |
| 2024-09-30 | $6.0M | 293k | 20.55 |
| 2024-06-30 | $5.6M | 249k | 22.38 |
| 2024-03-31 | $8.3M | 303k | 27.50 |
| 2023-12-31 | $14M | 467k | 30.49 |
| 2023-09-30 | $8.1M | 257k | 31.50 |
| 2023-06-30 | $9.1M | 223k | 40.79 |
| 2023-03-31 | $8.4M | 226k | 37.25 |
| 2022-12-31 | $9.1M | 260k | 35.00 |
| 2022-09-30 | $10M | 185k | 55.96 |
| 2022-06-30 | $5.5M | 107k | 51.75 |
| 2022-03-31 | $7.3M | 101k | 72.66 |
| 2021-12-31 | $17M | 146k | 118.24 |
| 2021-09-30 | $17M | 129k | 134.17 |
| 2021-06-30 | $25M | 153k | 161.89 |
| 2021-03-31 | $16M | 202k | 80.25 |
| 2020-12-31 | $929k | 17k | 54.40 |
| 2020-09-30 | $597k | 30k | 19.87 |
| 2020-06-30 | $632k | 30k | 21.04 |
| 2020-03-31 | $320k | 26k | 12.23 |
| 2019-12-31 | $668k | 46k | 14.68 |
| 2019-09-30 | $260k | 20k | 13.31 |
| 2019-06-30 | $413k | 25k | 16.36 |
| 2019-03-31 | $162k | 9.5k | 17.04 |
| 2018-12-31 | $209k | 15k | 13.66 |
| 2018-09-30 | $466k | 16k | 28.59 |
| 2018-06-30 | $205k | 7.5k | 27.46 |
| 2018-03-31 | $417k | 20k | 21.06 |
| 2017-12-31 | $179k | 9.3k | 19.24 |
| 2017-09-30 | $172k | 6.9k | 24.83 |
| 2017-06-30 | $0 | 2.1k | 0.00 |
| 2017-03-31 | $269k | 19k | 14.24 |
| 2016-12-31 | $150k | 11k | 13.37 |
| 2016-09-30 | $1.0k | 68 | 14.93 |
| 2016-06-30 | $10k | 490 | 20.41 |